Stem Cell

Stem Cell

ICO Ended
13,261 Views
At SCI, we are devoted to the international research, development, and implementation of stem cell therapy. We are also expanding our network with professionals, labs, clinics, hospitals, and nonprofit organizations. Our ultimate goal at SCI is to connect people who need treatment with the right dedicated solutions and professionals for their unique needs. At SCI, we believe such connections should be convenient and at your fingertips, just as so many other services are in modern society. We imagine a world where each and every person, no matter where they come from, will be able to connect with a Stem Cel Specialist instantly through our Stem Cell Innovations application (SCI Application), and in the same connection be able to decide when and how much confidential information to share with professionals.
8.4
TOTAL SCORE
8.1
ICO PROFILE

(weight: 45%)

10
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 17 Sept 2018 - 09 Oct 2018
ICO Time: 21 Nov 2018 - 17 Jan 2019
Whitelist/KYC: KYC
Country: Gibraltar
Token info
Ticker: SCI
Platform: Ethereum
Token Type: ERC20
Available for sale: 800,000,000 SCI
Financial
ICO Price: 1 SCI = 0.15 USD
Accepting: BTC, ETH, LTC, Fiat
Soft cap: 3,000,000 USD
Hard cap: 36,000,000 USD
2013
Establishment of Camden RAD, LLC, a company devoted to stem cell research and development.
Q4 2017
Camden RAD, LLC is rebranded as Stem Cell Innovations, and a new company is established, based on blockchain technology.<br /> <br /> Advanced research begins to determine market and development opportunities.
Q1 2018
Attended Token 2049 conference in Hong Kong.<br /> <br /> Attended Stem Cell Summit at the University of California in Los Angeles (UCLA).<br /> <br /> Attended CBC conference in San Francisco, CA.<br />
Q2 2018
Attended ICO20 Summit in Santa Monica, CA.<br /> <br /> Integration of smart contract technology is established.<br /> <br /> Company headquarters incorporated in Gibraltar, GB.<br /> <br /> Strategic efforts toward development begins.<br /> <br /> Interviews with potential medical participants take place.
Q3 2018
Whitelist is scheduled to go live.<br /> <br /> Token Sale starts.
Q4 2018
Token Sale ends and min max caps are assessed.<br /> <br /> Distribution of Tokens to participants through ERC20 will commence.
Q1 2019
SCI will begin final testing and reporting based on blockchain technology being used.<br /> <br /> Creation of a non-identical patient identification factor on Passive Blockchain Node will be initialized.<br /> <br /> Demo testing for SCI Application v 1.0 will begin.
Q2 2019
Release of the SCI Application v1.1<br /> <br /> Enrollment begins for doctors, patients, and stem cell laboratories in the United States
Q3 2019
Release of Market Surveillance strategy for further growth<br /> <br /> Release SCI Application v2.0<br /> <br /> Enrollment begins for professionals, patients, and stem cell laboratories in Middle East and across North Africa.<br /> <br /> Announcement of first SCI Lab location and franchise expansion plan.
Q4 2019
Announcement of clinical development and research strategy in the stem cell field.<br /> <br /> Public announcement regarding SCI achievements to date.<br /> <br /> First ever online synthetic stem cell purchase through the SCI Application. Release SCI Application v3.0, fully functional platform for professionals and patients.
Q1 2020
Stem Cell Lab Evaluation report per first year of operation and development.<br /> <br /> Release SCI earnings and financials report.<br /> <br /> Release results of SCI's stem cell research and development to date.<br />
Q2 2020
Expansion of SCI stem cell labs and clinics in China, Japan, South Korea, and India.<br /> <br /> Begin charging membership fees (payable in Stem Cell Innovations tokens) for professional-facing portion of SCI application.
Q3 2020
Begin second phase of SCI stem cell research and development.<br /> <br /> Release SCI Application v3.5, including professional-facing component to help practitioners become more involved in the stem cell research space and contribute to the network.
Q4 2020
Expansion and acquisition of SCI stem cell labs and clinics in Europe.
Q1 2021
Release SCI earnings and financials report for second year operation and development.<br /> <br /> Release public update on SCI stem cell research and development.<br /> <br /> Stem Cell Lab Evaluation report for second year.
Q2 2021
Release SCI Application v4.0 including:<br /> <br /> A new platform for medical students, universities, and hospitals to engage with the SCI Application.<br /> <br /> Fully Functional EMR Worldwide Enforcing HIPPA and expanding of synthetic stem cell delivery to Latin America.
Screenshots taken on 13 Sep 2018
Moe Galal
Chief Executive Officer / Founder
Participates in a number of projects
Ben Barel
Chief Operations Officer / Co-Founder
Participates in a number of projects
Ali Alrashidi
Chief Technology Officer / Co-Founder
Participates in a number of projects
Matt Galal
Chief of Staff / Co-Founder
Participates in a number of projects
Kobi Barel
Operations Engineer / Co-Founder
Participates in a number of projects
John Glavinovich, M.D.
Medical Director
Participates in a number of projects
Philip Glukhovsky, D.C.
Health Informatics Manager
Participates in a number of projects
Roger Williams
VP of Marketing
Participates in a number of projects
Liz Curlett
VP, PR & Corporate Communications
Participates in a number of projects
Candice Kouchache
Business Development
Participates in a number of projects
Ahmed Elsantawi
VP of International Human Resources
Participates in a number of projects
David Marmon
Web Designer
Participates in a number of projects
Heather Deveaux
Copywriter
Participates in a number of projects
Everlecia Taylor
Creative Writer
Participates in a number of projects
Marina Evglevskaya
Administrative Manager
Participates in a number of projects
Rakel Apodaca
Product Manager
Participates in a number of projects
Michelle Chavon
Marketing
Participates in a number of projects

Advisors (7)

Boyan Josic
Participates in a number of projects
Marc X. Ellul
Participates in a number of projects
Roger Shortz, M.D.
Participates in a number of projects
Greg Maddex, D.O
Participates in a number of projects
Pantea Nakieen, M.D.
Participates in a number of projects
Shahab Sajadi
Participates in a number of projects
Igor Soshkin
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Burency
Burency is an advocate for crypto and Blockchain adoption, particularly in the MIDDLE EAST. The platform is designed to address key challenges that prevent widespread adoption within the cryptocurrency and Blockchain ecosystem such as exchange’s lack of liquidity and security, unsustainable mining, unawareness of Blockchain applications to businesses. The Burency Exchange is a regulated exchange platform that addresses key challenges including security, liquidity, fiat to crypto transactions and vise versa, and more. The exchange is one of the world’s fully insured platforms, with coverage provided from LIoyd’s of London through the Nebbex Protocol. The Burency Mining facility answers some of the challenges associated with crypto mining such as mining destruction to environment and excessive mining power expenses by creating a sustainable facility powered by renewable hydropower. Burency provides a streamlined platform for the generation of cryptocurrency via purchased timeshare slots within the mining facilities using the BUY token. Additionally, computational power can also be purchased via the BUY token which governs purchases across the Burency ecosystem. The Burency Blockchain Development Center is dedicated mainly for advising enterprises on Blockchain applications and helping them operate on the blockchain for more efficient operation and business transactions execution. In particular, the center focuses on the creation of smart contracts that enable businesses to trade with entities across geographical and jurisdiction boundaries.
Upcoming
Digital Ticks
A First ever Commodity - Crypto Exchange well designed by traders for traders. Digital Ticks Exchange (DTX) is just not another crypto to crypto exchange but is also a semi-algorithm platform provider in its own. DTX plans to cater to all types of crypto assets as well as commodity to crypto assets. DTX would be power packed by a lot of advanced features including all the basic features of an exchange required by a novice trader to a professional trader as well as for a high frequency trader. In terms of security DTX is taking extra precautionary measures to avoid any kind of hacks like DDoS attacks, phishing attempts and by also performing vulnerability assessments and penetration testing. DTX has installed robust technologies behind the scene that could handle heavy volatility of the crypto markets as well as commodity markets which can handle upto 1,000,000 orders per second. Digital Ticks Exchange team believes into robust technology, ahead of industry standards in terms of providing customer service to its stakeholders as well as traders. Digital Ticks Exchange team ensures all its traders to have a smooth and user friendly trading experience. Digital Ticks Exchange would not levy any transaction charges for first few months of inception thereby giving traders to trade on zero transaction charges. DTX would give volume-based incentive for high frequency trader (HFT) which would give them scope for retaining higher profitability in the trade.
Upcoming
Gluon
Gluon’s platform establishes an interconnected network of vehicles where individuals and businesses can monitor, track, tune, and diagnose the issues in them. Not only can customers diagnose their vehicles themselves, order parts, and request bids on repairs, but they can schedule repairs, send/receive payments for services and goods. Consumers can tune their vehicles for optimal performance and/or regulate their use.Repair shops can diagnose vehicles more cost-effectively and accurately order the correct parts. Vehicle service record, repairs, diagnostics, smog tests are all stored in the Gluon secure blockchain based on the Stratis Platform.
Upcoming
AllPublicArt
All Public Art (APA) provides a unique platform that contributes to the growth and sustainability of the global art community by supporting the art market, igniting artist-to-collector trading, and storing the provenance of art on the blockchain. With the AllPublicArt token and the creation of our API, we are deploying a new, convenient and effective way to trade art and track the history of artworks. All Public Art's implementation of blockchain technology will minimize counterfeit art, build trust within the art market, improve art trade services and increase economic and social benefits in the global art community. Thanks to blockchain technology, transparency is increased ensuring a more convenient and legitimate marketplace for trading art.
Upcoming
Allabout.me
A DIGITAL NETWORK USER = A CRYPTOCURRENCY BANK CLIENT Allabout.me is the first social network based on Bitcoin and the internal token of the project ALL.ME. All.me built-in a personal wallet in every user's account. A person creates an account and becomes a client of the internal cryptocurrency bank.